Quantcast
Last updated on April 18, 2014 at 8:42 EDT

Latest Antiretroviral drug Stories

2012-12-03 12:27:36

CHICAGO, Dec. 3, 2012 /PRNewswire/ -- More than 20,000 people are living with HIV/AIDS in Chicago - three times the national prevalence rate. In some Chicago neighborhoods, HIV rates have climbed to a staggering 53 percent in recent years. That's why the AIDS Foundation of Chicago (AFC) is marking this World AIDS Day by announcing a new campaign called Need2Know HIV, an initiative to educate people about the importance of HIV testing. In partnership with Abbott, a...

2012-12-01 08:20:12

PITTSBURGH, Dec. 1, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today joins communities around the world to commemorate the 24th World AIDS Day by honoring those who have battled HIV/AIDS, celebrating the progress achieved to date in the global response to the disease, and reaffirming Mylan's passionate commitment to the ongoing fight against HIV/AIDS. Mylan CEO Heather Bresch said, "Mylan is dedicated to expanding access to high quality antiretroviral medications (ARVs) for those in need....

Dual Defense Against Pregnancy And HIV Offered By Electrically Spun Fabric
2012-11-30 14:47:36

University of Washington The only way to protect against HIV and unintended pregnancy today is the condom. It's an effective technology, but not appropriate or popular in all situations. A University of Washington team has developed a versatile platform to simultaneously offer contraception and prevent HIV. Electrically spun cloth with nanometer-sized fibers can dissolve to release drugs, providing a platform for cheap, discrete and reversible protection. The research was published this...

2012-11-30 14:15:01

New research published in the Journal of Leukocyte Biology suggests that JQ1 can reactivate latent HIV and potently suppress inflammation, making it effective against HIV and other inflammatory conditions Breakthrough drugs have made it possible for people to live with HIV longer than ever before, but more work must be done to actually cure the disease. One of the challenges researchers face involves fully eradicating the virus when it is latent in the body. A new report appearing in the...

2012-11-29 14:36:09

A combination of anti-HIV drugs has been found to also reduce the risk of recurrent malaria by nearly half among HIV-positive children, according to researchers supported by the National Institutes of Health. The combination of protease inhibitors lopinavir and ritonavir contributed to an overall reduction of 40 percent in the rate of malaria among a group of HIV-positive infants and children up to 6 years old in Uganda who were also being treated with anti-malarial drugs. This...

2012-11-29 08:30:07

RARITAN, N.J., Nov. 29, 2012 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced their intention not to enforce the patents they own and control on the antiretroviral (ARV) drug darunavir provided the darunavir product is medically acceptable and is used only in resource-limited settings.(1) This announcement is intended to assure generic manufacturers that they may manufacture high quality darunavir product used in SSA and the LDCs without a concern...

2012-11-29 08:29:43

JOHANNESBURG and PITTSBURGH, Nov. 29, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) announced today that its subsidiary in India, Mylan Laboratories Ltd., a leading manufacturer of antiretroviral (ARV) drugs, has been selected, through its South African-based subsidiary Mylan (Proprietary) Limited (Mylan Limited), as one of the leading suppliers of ARV drugs to the South African National Department of Health for the tender period January 1, 2013 to December 31, 2014. Mylan Limited secured a...

2012-11-29 08:25:02

LONDON, November 29, 2012 /PRNewswire/ -- To mark Worlds AIDS Day (December 1, 2012), Women for Positive Action has released a commentary highlighting the shortage of women in HIV clinical trials (currently only ~20%) and discussing recent scientific papers reporting gender-related differences in virologic and clinical outcomes with combination antiretroviral therapy. The commentary, available at: http://www.womenforpositiveaction.org...

2012-11-27 12:29:02

Summit on HIV and Viral Hepatitis Charts Priorities to Accelerate Testing, Reduce Disparities in Care WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- As the countdown to implementation of the Affordable Care Act begins in earnest, experts on the front lines in fighting viral hepatitis and HIV/AIDS issued this harsh assessment regarding escalating levels of hepatitis C virus (HCV) infection: unless policymakers require insurers to cover the costs of screening everyone at potential...

2012-11-19 20:22:18

USPSTF GRADE CHANGE WILL INCREASE ACCESS TO HIV CARE AND DECREASE NEW INFECTIONS WASHINGTON, Nov. 19, 2012 /PRNewswire-USNewswire/ -- The U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation today in strong support of routine HIV testing for ALL adolescents and adults ages 15 through 65. Until now, the Task Force recommended testing only for people who are at risk for HIV and pregnant women. "This marks a monumental shift in how HIV in the United States...


Latest Antiretroviral drug Reference Libraries

0_a4499f7c8759b5cbe79bad5eca319070
2011-01-26 14:08:59

Human immunodeficiency virus (HIV), a lentivirus, causes acquired immunodeficiency syndrome (AIDS) which is a condition in humans were the immune system begins to fail, leading to life-threatening opportunistic infections. Infection is transferred through bodily fluids where HIV is present as both free virus particles and within infected immune cells. The four most common routes of infection are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her...

More Articles (1 articles) »